More and more people are talking about Welltower over the last few weeks. Is it worth buying the Specialty Real Estate Investment Trust stock at a price of $91.87? Only time will tell. The information below will give you a basic idea of what this investment may entail:
-
Welltower has moved 35.4% over the last year, and the S&P 500 logged a change of 20.8%
-
WELL has an average analyst rating of buy and is 0.17% away from its mean target price of $91.71 per share
-
Its trailing earnings per share (EPS) is $0.53
-
Welltower has a trailing 12 month Price to Earnings (P/E) ratio of 173.3 while the S&P 500 average is 15.97
-
Its forward earnings per share (EPS) is $1.2 and its forward P/E ratio is 76.6
-
The company has a Price to Book (P/B) ratio of 2.13 in contrast to the S&P 500's average ratio of 2.95
-
Welltower is part of the Real Estate sector, which has an average P/E ratio of 25.55 and an average P/B of 2.1
-
The company has a free cash flow of $2.47 Billion, which refers to the total sum of all its inflows and outflows of cash over the last quarter
-
Welltower Inc. (NYSE:WELL), a real estate investment trust ("REIT") and S&P 500 company headquartered in Toledo, Ohio, is driving the transformation of health care infrastructure. Welltower invests with leading seniors housing operators, post-acute providers and health systems to fund the real estate infrastructure needed to scale innovative care delivery models and improve people's wellness and overall health care experience. Welltower, owns interests in properties concentrated in major, high-growth markets in the United States, Canada and the United Kingdom, consisting of seniors housing and post-acute communities and outpatient medical properties.